Annual Non Current Assets
$3.07 M
-$12.24 M-79.97%
December 31, 2023
Summary
- As of February 8, 2025, ENLV annual long term assets is $3.07 million, with the most recent change of -$12.24 million (-79.97%) on December 31, 2023.
- During the last 3 years, ENLV annual non current assets has risen by +$830.00 thousand (+37.10%).
- ENLV annual non current assets is now -79.97% below its all-time high of $15.31 million, reached on December 31, 2022.
Performance
ENLV Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$2.69 M
-$646.00 K-19.39%
September 30, 2024
Summary
- As of February 8, 2025, ENLV quarterly long term assets is $2.69 million, with the most recent change of -$646.00 thousand (-19.39%) on September 30, 2024.
- Over the past year, ENLV quarterly non current assets has dropped by -$12.41 million (-82.21%).
- ENLV quarterly non current assets is now -88.03% below its all-time high of $22.44 million, reached on March 31, 2023.
Performance
ENLV Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
ENLV Non Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -80.0% | -82.2% |
| 3 y3 years | +37.1% | -88.0% |
| 5 y5 years | +305.1% | -88.0% |
ENLV Non Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -80.0% | at low | -88.0% | +0.6% |
| 5 y | 5-year | -80.0% | +169.3% | -88.0% | +156.5% |
| alltime | all time | -80.0% | -100.0% | -88.0% | -100.0% |
Enlivex Therapeutics Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.69 M(-19.4%) |
| Jun 2024 | - | $3.33 M(+24.7%) |
| Mar 2024 | - | $2.67 M(-12.9%) |
| Dec 2023 | $33.76 M(-35.5%) | $3.07 M(-79.7%) |
| Sep 2023 | - | $15.10 M(-32.1%) |
| Jun 2023 | - | $22.24 M(-0.9%) |
| Mar 2023 | - | $22.44 M(+46.6%) |
| Dec 2022 | $52.33 M(-39.5%) | $15.31 M(+16.1%) |
| Sep 2022 | - | $13.18 M(+7.3%) |
| Jun 2022 | - | $12.29 M(+31.8%) |
| Mar 2022 | - | $9.32 M(+7.1%) |
| Dec 2021 | $86.44 M(+126.8%) | $8.70 M(+10.4%) |
| Sep 2021 | - | $7.89 M(+234.3%) |
| Jun 2021 | - | $2.36 M(+7.9%) |
| Mar 2021 | - | $2.19 M(-2.3%) |
| Dec 2020 | $38.12 M(+132.1%) | $2.24 M(+26.7%) |
| Sep 2020 | - | $1.77 M(+60.1%) |
| Jun 2020 | - | $1.10 M(+5.3%) |
| Mar 2020 | - | $1.05 M(-8.1%) |
| Dec 2019 | $16.42 M | $1.14 M(-0.9%) |
| Sep 2019 | - | $1.15 M(-8.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $1.25 M(-1.3%) |
| Mar 2019 | - | $1.27 M(+67.5%) |
| Dec 2018 | $10.28 M(+183.7%) | $757.00 K(>+9900.0%) |
| Jun 2018 | - | $0.00(0.0%) |
| Dec 2017 | $3.62 M(-65.6%) | $0.00(0.0%) |
| Sep 2017 | - | $0.00(0.0%) |
| Jun 2017 | - | $0.00(-100.0%) |
| Mar 2017 | - | $87.00 K(-2.2%) |
| Dec 2016 | $10.54 M(-48.3%) | $89.00 K(-6.3%) |
| Sep 2016 | - | $95.00 K(-34.0%) |
| Jun 2016 | - | $144.00 K(-4.6%) |
| Mar 2016 | - | $151.00 K(+21.8%) |
| Dec 2015 | $20.39 M(-38.0%) | $124.00 K(+8.8%) |
| Sep 2015 | - | $114.00 K(+32.6%) |
| Jun 2015 | - | $86.00 K(+1.2%) |
| Mar 2015 | - | $85.00 K(+23.2%) |
| Dec 2014 | $32.88 M(>+9900.0%) | $69.00 K(+6.2%) |
| Sep 2014 | - | $65.00 K(-49.6%) |
| Jun 2014 | - | $129.00 K(+1742.9%) |
| Dec 2013 | $299.00 K(+91.7%) | $7000.00 |
| Dec 2012 | $156.00 K | - |
FAQ
- What is Enlivex Therapeutics annual long term assets?
- What is the all time high annual non current assets for Enlivex Therapeutics?
- What is Enlivex Therapeutics annual non current assets year-on-year change?
- What is Enlivex Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for Enlivex Therapeutics?
- What is Enlivex Therapeutics quarterly non current assets year-on-year change?
What is Enlivex Therapeutics annual long term assets?
The current annual non current assets of ENLV is $3.07 M
What is the all time high annual non current assets for Enlivex Therapeutics?
Enlivex Therapeutics all-time high annual long term assets is $15.31 M
What is Enlivex Therapeutics annual non current assets year-on-year change?
Over the past year, ENLV annual long term assets has changed by -$12.24 M (-79.97%)
What is Enlivex Therapeutics quarterly long term assets?
The current quarterly non current assets of ENLV is $2.69 M
What is the all time high quarterly non current assets for Enlivex Therapeutics?
Enlivex Therapeutics all-time high quarterly long term assets is $22.44 M
What is Enlivex Therapeutics quarterly non current assets year-on-year change?
Over the past year, ENLV quarterly long term assets has changed by -$12.41 M (-82.21%)